Context Therapeutics Inc (CNTX) Stock Analysis

Context Therapeutics Inc (CNTX) is a publicly traded company in the HEALTHCARE sector. It trades at $2.42, carries a market capitalization of $256.34M. This page summarizes the public market data, fundamentals, and frequently asked questions for CNTX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.42
• Market Cap: $256.34M
• EPS: $-0.42
• 52-Week High: $3.62
• 52-Week Low: $0.52

Market Sentiment

Context Therapeutics Inc currently has a Bullish sentiment score of 0.43.

About Context Therapeutics Inc

Context Therapeutics Inc. is a Boston-based late-stage biopharmaceutical company focused on developing innovative non-opioid therapies for chronic pain management. The company is poised to make significant advancements in the treatment landscape with its robust pipeline addressing critical unmet medical needs. By prioritizing the development of non-addictive solutions, Context Therapeutics is dedicated to enhancing patient outcomes and reducing dependency on opioids, positioning itself as a l...

GNG Research Analysis

GNG Research scores Context Therapeutics Inc (CNTX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CNTX.

Frequently Asked Questions

Does CNTX pay dividends?

Context Therapeutics Inc (CNTX) does not currently pay a regular dividend.

What is CNTX's market cap?

Context Therapeutics Inc (CNTX) has a market capitalization of $256.34M with a current stock price of $2.42.